コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ibed hormone replacement therapy formulation Premarin.
2 ations and in new prescriptions for low-dose Premarin.
3 2003 declined by 66% for Prempro and 33% for Premarin.
4 ize of cholinergic neurons was unaffected by Premarin.
5 Equilin and equilenin, major components of Premarin, are predominantly metabolized to 4-hydroxyequi
6 nd treated with conjugated equine estrogens (Premarin) at doses that are equivalent to those currentl
7 ontrol), group 2 (n = 22) received estrogen (Premarin) at the human equivalent of 0.625 mg/day, and g
10 -1 (hGST P1-1) by the catechol metabolite of Premarin estrogens, 4-hydroxyequilenin (4-OHEN), was (we
11 f androgen-independent prostate cancer, oral premarin has been shown to induce of prostate specific a
12 These findings suggest that treatment with Premarin has selective beneficial effects on cholinergic
14 he intermediate region (Ch4i) was greater in Premarin-treated monkeys as compared to controls and num
15 al band (MS/DB), no effect of treatment with Premarin was observed in the cholinergic neurons in eith
16 mine whether use of postmenopausal estrogen (Premarin, Wyeth-Ayerst, Philadelphia, PA) in women with
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。